Inactivation of ATP7A in patients with Menkes disease causes Cu-deficiency in the brain, numerous metabolic abnormalities (including catecholamine misbalance), delayed neurodevelopment, and death in the early childhood [3]. This evidence concerns the gene ATP7A and Menkes disease.